Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/15020
Title: | Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer |
Authors: | Wilkerson, PM Dedes, KJ Samartzis, EP Dedes, I Lambros, MB Natrajan, R Gauthier, A Piscuoglio, S Töpfer, C Vukovic, V Daley, F Weigelt, B Reis-Filho, JS |
Issue Date: | 2017 |
Citation: | Oncotarget, 2017, 8 (4), pp. 6057 - 6066 |
Abstract: | Purpose: To determine if models of ovarian clear cell carcinomas (OCCCs) harbouring defects in homologous recombination (HR) DNA repair of double strand breaks (DSBs) are sensitive to cisplatin and/or PARP inhibition. Experimental Design: The HR status of 12 OCCC cell lines was determined using RAD51/γH2AX foci formation assays. Sensitivity to cisplatin and the PARP inhibitor BMN-673 was correlated with HR status. BRCA1, BRCA2, MRE11 and PTEN loss of expression was investigated as a potential determinant of BMN-673 sensitivity. A tissue microarray containing 50 consecutive primary OCCC was assessed for PTEN expression using immunohistochemistry. Results: A subset of OCCC cells displayed reduced RAD51 foci formation in the presence of DNA DSBs, suggestive of HR defects. HR-defective OCCC cells, with the exception of KOC-7c, had higher sensitivity to cisplatin/ BMN-673 than HR-competent OCCC cell lines (Log10 SF50 -9.4 (SD +/- 0.29) vs -8.1 (SD +/- 0.35), mean difference 1.3, p < 0.01). Of the cell lines studied, two, TOV-21G and KOC-7c, showed loss of PTEN expression. In primary OCCCs, loss of PTEN expression was observed in 10% (5/49) of cases. Conclusions: A subset of OCCC cells are sensitive to PARP inhibition in vitro, which can be predicted by HR defects as defined by γH2AX/RAD51 foci formation. These results provide a rationale for the testing of HR deficiency and PARP inhibitors as a targeted therapy in a subset of OCCCs. |
URI: | http://bura.brunel.ac.uk/handle/2438/15020 |
DOI: | http://dx.doi.org/10.18632/oncotarget.14011 |
ISSN: | 1949-2553 |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | 1.93 MB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.